2-(氨基甲基)-5-甲基吡嗪,CAS 登记号 132664-85-8,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于有机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。
有机化学品
每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。
本页已列出 2-(氨基甲基)-5-甲基吡嗪 的 CAS 号:132664-85-8,可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。
2-(AMINOMETHYL)-5-METHYLPYRAZINE · CAS 132664-85-8 · C6H9N3.
| CAS Registry Number | 132664-85-8 |
|---|---|
| PubChem CID | 2756496 |
| Molecular formula | C6H9N3 |
| IUPAC name | (5-methylpyrazin-2-yl)methanamine |
| Molecular Weight | 123.16 |
|---|---|
| XLogP3 | -0.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 123.079647300 |
| Monoisotopic Mass | 123.079647300 |
| Topological Polar Surface Area | 51.8 |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Reported hazard statements | H301 (92.9%), H318 (95.2%) |
|---|
H301 (92.9%): Toxic if swallowed [Danger Acute toxicity, oral]
H318 (95.2%): Causes serious eye damage [Danger Serious eye damage/eye irritation]
2-(Aminomethyl)-5-methylpyrazine; 132664-85-8; DTXSID90373396; RefChem:253126; DTXCID30324428; 671-087-6; (5-methylpyrazin-2-yl)methanamine; MFCD01314542; 2-Pyrazinemethanamine, 5-methyl-; (5-methylpyrazin-2-yl)methylamine; 1-(5-methylpyrazin-2-yl)methanamine; 5-Methyl-2-pyrazinemethanamine; (5-Methylpyrazin-2-yl)methanamine; 1-(5-Methyl-2-pyrazinyl)methanamine; Pyrazinemethanamine, 5-methyl-; 2-aminomethyl-5-methylpyrazine; SCHEMBL5476; 5-aminomethyl-2-methylpyrazine
CAS 132664-85-8; molecular formula C6H9N3; molecular weight — g/mol.
2-(Aminomethyl)-5-methylpyrazine, 132664-85-8, DTXSID90373396, RefChem:253126, DTXCID30324428, 671-087-6.
Hazard statements reported: H301, H318.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.